BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37141773)

  • 21. Encapsulation and Systemic Delivery of 5-Fluorouracil Conjugated with Silkworm Pupa Derived Protein Nanoparticles for Experimental Lymphoma Cancer.
    Reneeta NP; Thiyonila B; Aathmanathan VS; Ramya T; Chandrasekar P; Subramanian N; Prajapati VK; Krishnan M
    Bioconjug Chem; 2018 Sep; 29(9):2994-3009. PubMed ID: 30089206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered Targeted Hyaluronic Acid-Glutathione-Stabilized Gold Nanoclusters/Graphene Oxide-5-Fluorouracil as a Smart Theranostic Platform for Stimulus-Controlled Fluorescence Imaging-Assisted Synergetic Chemo/Phototherapy.
    Yang Y; Wang S; Wang C; Tian C; Shen Y; Zhu M
    Chem Asian J; 2019 May; 14(9):1418-1423. PubMed ID: 30829452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gold nanoparticles enhance 5-fluorouracil anticancer efficacy against colorectal cancer cells.
    Safwat MA; Soliman GM; Sayed D; Attia MA
    Int J Pharm; 2016 Nov; 513(1-2):648-658. PubMed ID: 27693737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronotherapy with 5-fluorouracil and folinic acid in advanced colorectal carcinoma. Results of a chronopharmacologic phase I trial.
    Adler S; Lang S; Langenmayer I; Eibl-Eibesfeldt B; Rump W; Emmerich B; Hallek M
    Cancer; 1994 Jun; 73(12):2905-12. PubMed ID: 8199987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles.
    Wang Y; Li P; Chen L; Gao W; Zeng F; Kong LX
    Drug Deliv; 2015 Feb; 22(2):191-8. PubMed ID: 24437926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nano Codelivery of Oxaliplatin and Folinic Acid Achieves Synergistic Chemo-Immunotherapy with 5-Fluorouracil for Colorectal Cancer and Liver Metastasis.
    Guo J; Yu Z; Das M; Huang L
    ACS Nano; 2020 Apr; 14(4):5075-5089. PubMed ID: 32283007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transferrin receptors/magnetic resonance dual-targeted nanoplatform for precise chemo-photodynamic synergistic cancer therapy.
    Ge P; Liu Y; Chen Q; Su Z; Du Y; Luo S; Zhao X; Cao X; Song H; Zhu X
    Nanomedicine; 2022 Jan; 39():102467. PubMed ID: 34610478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-in-One Self-Assembled Nanocarrier for Dual-Drug Delivery, Two-Photon Imaging, and Chemo-Photodynamic Synergistic Therapy.
    Yang GG; Hao L; Cao Q; Zhang H; Yang J; Ji LN; Mao ZW
    ACS Appl Mater Interfaces; 2018 Aug; 10(34):28301-28313. PubMed ID: 30063824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
    Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P
    Cancer Chemother Pharmacol; 1996; 38(3):292-7. PubMed ID: 8646806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
    Hou L; Shan X; Hao L; Feng Q; Zhang Z
    Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoceria-Mediated Drug Delivery for Targeted Photodynamic Therapy on Drug-Resistant Breast Cancer.
    Li H; Liu C; Zeng YP; Hao YH; Huang JW; Yang ZY; Li R
    ACS Appl Mater Interfaces; 2016 Nov; 8(46):31510-31523. PubMed ID: 27933980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
    Srivastava S; Gupta S; Mohammad S; Ahmad I
    J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid-modified bovine serum albumin nanoparticles with doxorubicin and chlorin e6 for effective combinational chemo-photodynamic therapy.
    Lee H; Kim S; Oh C; Khan I; Shukla S; Bajpai VK; Han YK; Huh YS
    Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111343. PubMed ID: 32919690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast Tumor Targeting with PAMAM-PEG-5FU-
    Narmani A; Arani MAA; Mohammadnejad J; Vaziri AZ; Solymani S; Yavari K; Talebi F; Darzi SJ
    Biomed Microdevices; 2020 Apr; 22(2):31. PubMed ID: 32335724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Graphene oxide (GO)-based nanosheets with combined chemo/photothermal/photodynamic therapy to overcome gastric cancer (GC) paclitaxel resistance by reducing mitochondria-derived adenosine-triphosphate (ATP).
    Guo W; Chen Z; Feng X; Shen G; Huang H; Liang Y; Zhao B; Li G; Hu Y
    J Nanobiotechnology; 2021 May; 19(1):146. PubMed ID: 34011375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Trojan horse biomimetic delivery strategy using mesenchymal stem cells for PDT/PTT therapy against lung melanoma metastasis.
    Ouyang X; Wang X; Kraatz HB; Ahmadi S; Gao J; Lv Y; Sun X; Huang Y
    Biomater Sci; 2020 Feb; 8(4):1160-1170. PubMed ID: 31848537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adding weekly irinotecan to high-dose 5-fluorouracil and folinic acid (HD-5-FU/FA) after failure for first-line HD-5-FU/FA in advanced colorectal cancer--a phase II study.
    Hofheinz R; Hartung G; Samel S; Emig M; Pilz L; Willeke F; Hochhaus A; Hehlmann R; Queisser W
    Anticancer Drugs; 2002 Nov; 13(10):999-1004. PubMed ID: 12439333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving cytotoxicity against cancer cells by chemo-photodynamic combined modalities using silver-graphene quantum dots nanocomposites.
    Habiba K; Encarnacion-Rosado J; Garcia-Pabon K; Villalobos-Santos JC; Makarov VI; Avalos JA; Weiner BR; Morell G
    Int J Nanomedicine; 2016; 11():107-19. PubMed ID: 26766909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A tumor pH-responsive autocatalytic nanoreactor as a H
    Liu F; He T; Gong S; Shen M; Ma S; Huang X; Li L; Wang L; Wu Q; Gong C
    Acta Biomater; 2022 Dec; 154():510-522. PubMed ID: 36241016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.